PIB Headquarters
PIBβS BULLETIN ON COVID-19
Posted On:
19 SEP 2021 2:11PM by PIB Delhi
- 80.43 Cr. vaccine doses have been administered so far under Nationwide Vaccination Drive
- 30,773 new cases in the last 24 hours
- Active cases account for 0.99% of total cases
- India's Active caseload stands at 3,32,158
- Recovery Rate currently at 97.68%
- 38,945 recoveries in the last 24 hours increases Total Recoveries to 3,26,71,167
- Weekly Positivity Rate (2.04%) less than 3% for last 86 days
- Daily positivity rate (1.97%) less than 3% for last 20 days
- 55.23 crore Total Tests conducted so far
|
#Unite2FightCorona #IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
c
COVID-19 Update
India’s Cumulative COVID-19 Vaccination Coverage crosses the landmark of 80 Cr
More than 85 Lakh doses administered in last 24 hours
Recovery Rate currently at 97.68%
30,773 New Cases reported in the last 24 hours
India's Active Caseload (3,32,158) is 0.99% of Total Cases
Weekly Positivity Rate (2.04%) less than 3% for last 86 days
With the administration of 85,42,732 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage surpassed the landmark figure of 80 Cr (80,43,72,331) as per provisional reports till 7 am today. This has been achieved through 79,15,457 sessions.
The break-up of the cumulative figure as per the provisional report till 7 am today include:
HCWs
|
1st Dose
|
1,03,68,565
|
2nd Dose
|
87,23,015
|
FLWs
|
1st Dose
|
1,83,44,648
|
2nd Dose
|
1,44,80,304
|
Age Group 18-44 years
|
1st Dose
|
32,53,21,724
|
2nd Dose
|
5,91,05,510
|
Age Group 45-59 years
|
1st Dose
|
15,03,91,317
|
2nd Dose
|
6,87,57,707
|
Over 60 years
|
1st Dose
|
9,66,20,196
|
2nd Dose
|
5,22,59,345
|
Total
|
80,43,72,331
|
The recovery of 38,945 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,26,71,167.
Consequently, India’s recovery rate stands at 97.68%.
Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 84 consecutive days now.
30,773 new cases were reported in the last 24 hours.
The Active Caseload is presently 3,32,158. Active cases presently constitute 0.99% of the country's total Positive Cases.
The testing capacity across the country continues to be expanded. The last 24 hours saw a total of
15,59,895 tests being conducted. India has so far conducted over 55.23 Cr (55,23,40,168) cumulative tests.
While testing capacity has been enhanced across the country, Weekly Positivity Rate at 2.04% remains less than 3% for the last 86 days now. The Daily Positivity rate reported to be 1.97%. The daily Positivity rate has remained below 3% for last 20 days and below 5% for 103 consecutive days now.
Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1756183
Update on COVID-19 Vaccine Availability in States/UTs
More than 78.58 Crore vaccine doses provided to States/UTs
More than 5.16 Crore balance and unutilized vaccine doses still available with States/UTs with more than 1.16 Crore doses in Pipeline
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
VACCINE DOSES
|
(As on 19th September 2021)
|
SUPPLIED
|
78,58,15,125
|
PIPELINE
|
1,16,11,210
|
BALANCE AVAILABLE
|
5,16,98,785
|
More than 78.58 crore (78,58,15,125) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category. Further, more than 1.16 Crore doses (1,16,11,210) are in the pipeline.
More than 5.16 Cr (5,16,98,785) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
Details: https://pib.gov.in/PressReleseDetail.aspx?PRID=1756185
Important Tweets
*********
AS
(Release ID: 1756239)
Visitor Counter : 917